(23) reported that Pol protein did not alter the level of NF-κB expression, but could prevent the activation of the non-canonical NF-κB pathway required for IFN-β activation by inhibiting the nuclear translocation of RelB/p52 and NF-κB subunits in hepatoma cells. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.